Today, researchers and clinicians want the ability to test for several different biomarkers on ... we are able to run these multiplex panels without sacrificing the exquisite sensitivity, precision or ...

Various assays are used for analyzing biomarkers; however, information about a single analyte is insufficient to draw accurate conclusions. Hence, multiplex assays are being increasingly adopted ...

A new multiplex diagnostic method appears poised to resculpt the biomarker landscape. NULISA, aka NUcleic acid Linked Immunosorbent Assay, can detect Aβ peptides, p-tau isoforms, and other potential ...

The SR-X is made for multiplex detection of up to ... A wide selection of Simoa® assay kits is offered to assess important biomarkers with far higher sensitivity than conventional immunoassay ...

Under a strategic partnership with Alamar Biosciences, Biognosys is a provider of choice of NULISA multiplex assay ... of NULISA proteomics assays for biomarker discovery in plasma and other ...

It allows for extensive biomarker profiling ... single-plex qPCR assays and under 15 hours for multiplex next-generation sequencing (NGS) assays, with integrated software for data analysis.

The global Biomarkers Market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to ...

As the prevalence of chronic diseases continues to rise, accompanied by advancements in biomarker discovery and validation, multiplex assays are emerging as a cornerstone for managing and ...

12 mo; p = 0.03). A subset of CRPC patients demonstrate increased p300/CBP activity based on a novel CTC biomarker assay. “With further development, this biomarker suite may be used to identify ...